SunTrust Banks Inc. began coverage on shares of Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) in a research note issued to investors on Thursday. The firm issued a buy rating and a $8.00 target price on the stock.
Other analysts have also issued reports about the company. Rodman & Renshaw reiterated a buy rating on shares of Ekso Bionics Holdings in a report on Sunday, July 31st. B. Riley initiated coverage on Ekso Bionics Holdings in a report on Wednesday, September 21st. They set a buy rating and a $8.00 price objective for the company. Finally, Zacks Investment Research upgraded Ekso Bionics Holdings from a sell rating to a hold rating in a report on Thursday, August 11th.
Shares of Ekso Bionics Holdings (NASDAQ:EKSO) opened at 5.97 on Thursday. The stock’s market cap is $98.10 million. Ekso Bionics Holdings has a 12 month low of $3.45 and a 12 month high of $10.08. The company has a 50-day moving average price of $4.48 and a 200-day moving average price of $5.41.
Ekso Bionics Holdings (NASDAQ:EKSO) last announced its quarterly earnings data on Thursday, July 28th. The company reported ($0.61) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.28) by $0.33. On average, analysts expect that Ekso Bionics Holdings will post ($1.74) EPS for the current fiscal year.
Receive News & Ratings for Ekso Bionics Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekso Bionics Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.